PROGRAMME WEDNESDAY 20 NOVEMBER 2013 WEDNESDAY 20 NOVEMBER 2013 8.00-9.00 Clinical Leaders Meeting-SHED 6, ROOM 1 8.30-9.45 Delegate Arrival and Registration Welcome | President NZSG and NZGNS: A/Prof Alan Fraser and Cathryn Whiteside 9.45-10.00 Convenors: Dr Jeffrey Wong and Cathryn Whiteside SESSION 1 | General Plenary Session (Joint session) Chair: A/Prof Alan Fraser and Dr Stephen Inns SHED 6, ROOM 1 10.00-10.30 Achieving quality endoscopy in the UK I Prof Matt Rutter 10.30-11.00 Crohn’s Disease and its Evolution: From Observations to Individualized Therapy I Dr David Rubin 11.00-11.20 Iron and the Liver I Dr Kris Kowdley 11.20-11.40 Quality colonoscopy: To and from the Caecum I Prof Michael Bourke 11.40-12.00 Advancing IBD Nursing in Europe I Marian O’Connor 12.00-1.00 Lunch and Exhibition SESSION 2 | Endoscopy Quality Improvement Programme Chair: Dr Tim King SHED 6, ROOM 1 1.00-1.35 The National Endoscopy Quality Improvement Programme I Mr David Theobald and Jenni Masters SESSION 3 | I BD SESSION 3A | Upper G I SESSION 3B | Nurses professional session Chair: Dr Stephen Inns SHED 6, ROOM 1 Chair: Dr David Rowbotham SHED 6, ROOM 2 Chair: Katherine Broome SHED 6, ROOM 4 Microbiota and faecal transplant Capsule Endoscopy: The next 5 years Endoscope Disinfection: Where are 1.40-2.10 1.40-2.10 1.40-2.10 we now? I Di Jones Host-microbe interactions have shaped the genetic architecture of Bravo: Wireless pH monitoring Knowledge and skills framework 2.10-2.25 2.10-2.25 2.10-2.25 infl ammatory bowel disease Iron defi ciency in infl ammatory bowel Genetic Counselling and Gastro 2.25-2.40 2.25-2.40 Impedance I Dr Ian Wilson 2.25-2.40 disease I Dr Melissa Haines Nurses I Michelle Lau The role of the infl ammatory bowel Emerging treatment options for Refl ux 2.40-3.00 2.40-3.00 2.40-3.00 Prison based HCV Clinics I Ying Eu disease nurse I Marian O’Connor 3.00-3.30 Afternoon Tea SESSION 4A | Paediatric Gastroenterology: SESSION 4 | Hepatitis C SESSION 4B | Nurses professional session cont’d What Adult Gastroenterologists Need to Know Chair: Prof Ed Gane SHED 6, ROOM 1 Cha ir: Ying Eu SHED 6, ROOM 4 Chair: Dr Helen Evans SHED 6, ROOM 2 Hepatitis C Treatments: The Next 5 Setting up a Colo-rectal Surgery 3.30-4.00 3.30-3.50 Coeliac Disease I A/Prof Don Cameron 3.30-3.50 Years I Dr Kris Kowdley Nurse led clinic I Jenny Keene Who to treat now and who to wait Stomaltherapy - Getting to the Guts 4.00-4.15 3.50-4.10 Paediatric IBD I Prof Andrew Day 3.50-4.10 of the Matter I Vicky Beban The Pilot HCV Community Assessment Transition: What happens when your Peri-procedural Diabetes Care 4.15-4.30 and Support Programme 4.10-4.30 patients become our patients? 4.10-4.30 The HCV Pilot: Benefi ts for Clinicians Dr 4.30-4.45 4.30-4.40 Questions 4.30-4.40 Questions 4.45-5.00 Questions 5.00-6.00 Welcome Function 7.00-Late Doctors Dinner and Nurses Dinner PROGRAMME THURSDAY 21 NOVEMBER 2013 THURSDAY 21 NOVEMBER 2013 7.00-8.00 The 2nd Annual Great Guts Fun Run (proudly sponsored by AbbVie) SESSION 5 | Luminal – Free Papers SESSION 5B | Nurses Free Papers SESSION 5A | Hepatology – Free Papers 1st Time Presenters Chair: Dr Jeffrey Wong SHED 6, ROOM 2 SHED 6, ROOM 1 Chair: Jenni Masters SHED 6, ROOM 4 Use of Fibroscan in the assessment A Silent Illness – Primary Biliary Osteoprotegerin: a pro-infl ammatory 8.30-8.45 8.30-8.45 of chronic hepatitis B infection 8.30-8.45 Cirrhosis: One Patient’s perspective role in IBD I Andrew Day Retrospective comparison of The Descriptive Epidemiology Radiofrequency and Microwave 8.45-9.00 of Infl ammatory Bowel Disease in 8.45-9.00 8.45-9.00 Bizarre Bezoars I Katrina Wheatley ablation for Hepatocellular Carcinoma Nelson, New Zealand I Darryl Fry A reduction in FODMAP intake Tenofovir use in chronic hepatitis B Reducing polypectomy readmission correlates strongly with a reduction in 9.00-9.15 9.00-9.15 infection women during pregnancy: 9.00-9.15 rates in Bowel Screening Pilot IBS symptoms-The FIBS study Auckland Experience I Judy Huang Programme I Thelma Turner Malnutrition Screening in Hospitalised 15 Years of Liver Transplant Colonoscopy: Supply and Demand Patients; Laboratory test (Prealbumin) Assessments for Chronic Liver 9.15-9.30 9.15-9.30 9.15-9.30 at Counties Manukau District Health versus Routine Clinical Assessment Disease: A Single Centre Experience Board I Naomi Reed The prevalence of abnormal liver mir-1247 is Down-Regulated in enzymes in New Zealand: fi ndings Medication Safety in 9.30-9.45 CpG island Methylator Phenotype 9.30-9.45 9.30-9.45 from the 2008/09 Adult Nutrition Gastroenterology I Yasmin Reddy Colorectal Cancers I Jennifer Liang Survey I Kirsten Coppell What do endoscopy nurses believe is Biliary dilatation induced by different T cell distribution in gastrointestinal necessary for a Nurse Endoscopist 9.45-10.00 9.45-10.00 opiate drugs – a case series 9.45-10.00 infl ammatory disorders I Elliott Dunn role to develop in New Zealand? 10.00-10.30 Morning Tea and Exhibition SESSION 6 | Presidential Young Investigators Free Papers SESSION 6A | Nurses Free Papers Con’td Chair: A/Prof Alan Fraser SHED 6, ROOM 1 Chair: Janice Duxfield SHED 6, ROOM 4 Preserved colonic meal response and functional evidence for Why so slow? Rapid Iron Polymaltose infusions are well tolerated 10.30-10.45 anastomotic nerve regeneration in patients with normal bowel 10.30-10.45 in an outpatient setting I Urmilla Kumar function following anterior resection I Ryash Vather Bitter taste receptors within the gastrointestinal tract Psychological factors and personality traits in Infl ammatory Bowel 10.45-11.00 10.45-11.00 Disease: How to understand our IBD Patients better? I Irit Bialik Spontaneous maturation of organoids grown from isolated human Optimise or switch?–What to do when IBD patients fail anti-TNF- 11.00-11.15 11.00-11.15 colonic biopsies I Ely Rodrigues drugs I Kirsten Rosser Patient preferences for care in end stage liver disease Christchurch Hospital Infl ammatory Bowel Disease (IBD) Audit 11.15-11.30 11.15-11.30 Nursing Outcomes I Holly Weale 11.40-12.00 Trans-Tasman Lecture–50 Years of Australian and New Zealand Paediatric Gastroenterology I A/Prof Don Cameron 12.00-13.00 Lunch and Exhibition & Formal Poster Round–Poster Judging SESSION 7 | Colon Cancer in IBD SESSION 7A | Nurses AGM SESSION 7B | RACP – Adult Medicine Chair: A/Prof Richard Gearry SHED 6, ROOM 1 Chair: Cathryn Whiteside SHED 6, ROOM 4 Young Investigators AwardsSHED 6, ROOM 2 Update in Colorectal Cancer in Colitis: Towards an Individualized Prevalence of autoantibodies in 1.00-1.20 Approach idiopathic infl ammatory myopathy and/ or interstitial pneumonia Dr Rama Kalluru Surveillance in IBD: The State of the 1.20-1.40 Art I Prof Matt Rutter Inhibition of 5-reductase type 1 with dutasteride in men increases body fat Reducing Colon Cancer Risk with 1.00-2.30 1.00-2.30 and impairs insulin sensitivity 1.40-2.00 Drugs I A/Prof Michael Schultz Surgery for Cancer in IBD Diagnosis of myocardial infarction after 2.00-2.20 coronary artery bypass grafting with high-sensitivity troponin: validation of the universal defi nition 2.20-2.30 Discussion 2.30-3.00 Afternoon Tea and Exhibition PROGRAMME THURSDAY 21 - FRIDAY 22 NOVEMBER 2013 SESSION 8 | Colonoscopy SESSION 8A | Liver Cancer SESSION 8B | Nurse Professional Session Chair: Dr Michael Burt SHED 6, ROOM 1 Chair: Dr Richard Stein SHED 6, ROOM 2 Chair: Kirsten Rosser SHED 6, ROOM 4 Advanced Polypectomy in the Colon Hepatocellular Carcinoma in New IBD for Endoscopy Nurses 3.00-3.30 3.00-3.20 3.00-3.30 Zealand I Prof Ed Gane What are the important KPI’s Diagnosis and staging of HCC in 2013 Nurses Role in Endoscopy Quality 3.30-3.50 3.20-3.40 3.30-3.45 Improvement I Jenni Masters Colonic Tatooing Standards for Endoscopic Facilities 3.50-4.00 3.40-4.00 Surgery for HCC I Mr Adam Bartlett 3.45-4.00 and Services I Di Jones SESSION 9 | Oral poster presentations (5x5min slots-3 slide poster SESSION 9A | Advanced ER in the UGIT presentations) Chair: Dr Stephen Inns SHED 6, ROOM 1 Chair: Dr Rees Cameron SHED 6, ROOM 2 Faecal S100A12 in healthy infants and children I Andrew Day Colorectal Cancer After Colonoscopy: Risk Factors And Survival Data Compared With Cancer Diagnosed At Time Of Colonoscopy I Nathan Atkinson Infl ammatory bowel disease patient preferences for a computerised over face-to-face psychological intervention 4.05-4.30 4.05-4.30 Video Cases I Prof Michael Bourke CAPER score as a prioritization tool for colonoscopy grading in colorectal cancer investigation in Bay of Plenty DHB Judy Huang Infl ammatory Bowel Disease Mortality in Canterbury, New Zealand I A Forbes 4.30-6.00 NZSG AGM I SHED 6, ROOM 2 7.00-Late Conference Dinner I The Renouf Foyer, Michael Fowler Centre, Wellington I Bilbo goes to the Sevens FRI DAY 22 NOVEMBER 2013 SESSION 10 | General Hepatology SESSION 10A | Nurses Hands on Session Chair: Dr Stephen Gerred SHED 6, ROOM 1 Chair: Katherine Broome SHED 6, ROOM 4 9.00-9.30 Non Alcholic fatty liver Disease I Dr Kris Kowdley 9.30-10.00 An Update on Hepatitis B In New Zealand I Prof Ed Gane Gastroenterologists role in the care of the patient with a Liver 10.00-10.30 transplant I Dr Dominic Ray-Chaudhuri 10.30-11.00 Morning Tea and Exhibition SESSION 11 | General Session (Joint Session) Chair: Dr Richard Stein SHED 6, ROOM 1 11.00-11.20 Colonoscopy Services Across New Zealand I A/Prof Susan Parry 11.20-11.40 Nurse Endoscopy in Australia I Di Jones 11.40-12.00 Population Colon Cancer Screening: How to achieve equity I A/Prof Diana Sarfati 12.00-12.15 Closing Remarks 12.15-1.15 NB: Prelim Programme is subject to change without notice
UNITED STATES OF AMERICA BEFORE THE FEDERAL ENERGY REGULATORY COMMISSION MOTION TO ANSWER AND ANSWER OF EXELON TO THE IDAHO PUBLIC UTILITIES COMMISSION Pursuant to Commission Rules 212 and 213,1 Exelon Corporation (“Exelon”) submits this limited Answer to the Answer filed by the Idaho Public Utilities Commission (“Idaho PUC”) in this proceeding. Exelon submits that Ce
T H E U N I V E R S I T Y O F M E L B O U R N E A N I M A L W E L F A R E C O M M I T T E E G U I D E L I N E S F O R G E N E R A L A N A E S T H E S I A A N D A N A L G E S I A O F C O M M O N L A B O R A T O R Y A N I M A L S I n t r o d u c t i o n Anaesthesia means without ('an') feeling ('aesthesia') and general anaesthetic agents are drugs which typically produce a progr